Literature DB >> 8609724

Interphase fluorescence in situ hybridization (FISH) as a powerful tool for the detection of aneuploidy in multiple myeloma.

M Flactif1, M Zandecki, J L Laï, F Bernardi, V Obein, F Bauters, T Facon.   

Abstract

Conventional cytogenetic (CC) studies performed in multiple myeloma (MM) are difficult because of the low proliferation rate of plasma cells (PC). The purpose of this study was to compare results obtained by CC and by FISH for the detection of numeric chromosomal changes in patients with MM. PC DNA content, CC and interphase FISH analysis were performed on 29 consecutive patients with MM. Fifteen patients (control group) had known Cytogenetic abnormalities identified by CC. The other 14 patients (study group) had a normal karyotype but an abnormal DNA content. Bone marrow material prepared for CC or cytospin slides were probed with classical satellite III or alpha satellite DNA sequences for chromosomes 3, 7, 8, 9, 11 and 15 (chromosomes 3, 7, 9, 11, 15 probes for hyperdiploid patients and the chromosome 8 probe for hypodiploid patients). In the control group, an unexplained discrepancy between CC and FISH occurred for only one chromosome in one patient. Also in this group, four patients had only one abnormal cell by CC and the numeric changes in these patients were always confirmed by FISH analysis. In the study group, FISH analysis showed an abnormal result in all but one patient. From these data, we conclude that FISH improves the detection of cytogenetic abnormalities in multiple myeloma. Using commercially available DNA probes for the most frequent numeric changes and slides for CC or cytospin slides, we demonstrated abnormal cytogenetics by FISH in 28/29 patients. In further studies, use of FISH could permit a more accurate description of numeric changes and their prognostic value in MM as well as an approach to clonal evolution. It would also be of interest in the study of monoclonal gammopathies of undetermined significance.

Entities:  

Mesh:

Year:  1995        PMID: 8609724

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  11 in total

Review 1.  Multiple myeloma: increasing evidence for a multistep transformation process.

Authors:  M Hallek; P L Bergsagel; K C Anderson
Journal:  Blood       Date:  1998-01-01       Impact factor: 22.113

2.  Fluorescence in situ hybridization analysis of chromosome aberrations in 60 Chinese patients with multiple myeloma.

Authors:  Xiao Gao; Chunming Li; Run Zhang; Ruifang Yang; Xiaoyan Qu; Hairong Qiu; Jiaren Xu; Hua Lu; Jianyong Li; Lijuan Chen
Journal:  Med Oncol       Date:  2011-05-25       Impact factor: 3.064

3.  Identification of unbalanced genome copy number abnormalities in patients with multiple myeloma by single-nucleotide polymorphism genotyping microarray analysis.

Authors:  Yuhei Kamada; Mamiko Sakata-Yanagimoto; Masashi Sanada; Aiko Sato-Otsubo; Terukazu Enami; Kazumi Suzukawa; Naoki Kurita; Hidekazu Nishikii; Yasuhisa Yokoyama; Yasushi Okoshi; Yuichi Hasegawa; Seishi Ogawa; Shigeru Chiba
Journal:  Int J Hematol       Date:  2012-09-13       Impact factor: 2.490

4.  Interphase Chromosome Flow-FISH.

Authors:  Keyvan Keyvanfar; Jason Weed; Prashanth Swamy; Sachiko Kajigaya; Rodrigo T Calado; Neal S Young
Journal:  Blood       Date:  2012-08-29       Impact factor: 22.113

5.  Amplification of 1q21 and other abnormalities in multiple myeloma patients from a tertiary hospital in singapore.

Authors:  Alvin S T Lim; Sathish Krishnan; Tse Hui Lim; Karen See; Yit Jun Ng; Yu Min Tan; Natasha Choo; Lai Ching Lau; Sim Leng Tien; Jun Ma; Daryl Tan
Journal:  Indian J Hematol Blood Transfus       Date:  2013-09-04       Impact factor: 0.900

Review 6.  Multiple Myeloma: Treatment is Getting Individualized.

Authors:  M B Agarwal
Journal:  Indian J Hematol Blood Transfus       Date:  2015-07-26       Impact factor: 0.900

7.  Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation.

Authors:  Ichiro Hanamura; James P Stewart; Yongsheng Huang; Fenghuang Zhan; Madhumita Santra; Jeffrey R Sawyer; Klaus Hollmig; Maurizio Zangarri; Mauricio Pineda-Roman; Frits van Rhee; Federica Cavallo; Bart Burington; John Crowley; Guido Tricot; Bart Barlogie; John D Shaughnessy
Journal:  Blood       Date:  2006-05-16       Impact factor: 22.113

Review 8.  Molecular aspects of multiple myeloma.

Authors:  G Pratt
Journal:  Mol Pathol       Date:  2002-10

9.  Combined morphological and interphase fluorescence in situ hybridization study in multiple myeloma of Chinese patients.

Authors:  M H Ng; A Kan; Y F Chung; I H Wong; K W Lo; N W Wickham; K I Lei; J C Lee
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

10.  Implication of heat shock factors in tumorigenesis: therapeutical potential.

Authors:  Aurelie De Thonel; Valerie Mezger; Carmen Garrido
Journal:  Cancers (Basel)       Date:  2011-03-07       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.